Ameritas Investment Partners’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2K | Hold |
3,731
| – | – | ﹤0.01% | 2292 |
|
|
2025
Q1 | $43.1K | Hold |
3,731
| – | – | ﹤0.01% | 2192 |
|
|
2024
Q4 | $31.6K | Hold |
3,731
| – | – | ﹤0.01% | 2431 |
|
|
2024
Q3 | $43.2K | Hold |
3,731
| – | – | ﹤0.01% | 2278 |
|
|
2024
Q2 | $44K | Buy |
3,731
+1,263
| +51% | +$14.9K | ﹤0.01% | 2217 |
|
|
2024
Q1 | $29.3K | Hold |
2,468
| – | – | ﹤0.01% | 2419 |
|
|
2023
Q4 | $30.2K | Hold |
2,468
| – | – | ﹤0.01% | 2396 |
|
|
2023
Q3 | $23.8K | Buy |
2,468
+918
| +59% | +$8.84K | ﹤0.01% | 2456 |
|
|
2023
Q2 | $14K | Hold |
1,550
| – | – | ﹤0.01% | 2756 |
|
|
2023
Q1 | $12.2K | Hold |
1,550
| – | – | ﹤0.01% | 2656 |
|
|
2022
Q4 | $12.3K | Hold |
1,550
| – | – | ﹤0.01% | 2752 |
|
|
2022
Q3 | $22K | Hold |
1,550
| – | – | ﹤0.01% | 2481 |
|
|
2022
Q2 | $15K | Hold |
1,550
| – | – | ﹤0.01% | 2686 |
|
|
2022
Q1 | $23K | Hold |
1,550
| – | – | ﹤0.01% | 2494 |
|
|
2021
Q4 | $21K | Hold |
1,550
| – | – | ﹤0.01% | 2622 |
|
|
2021
Q3 | $27K | Hold |
1,550
| – | – | ﹤0.01% | 2532 |
|
|
2021
Q2 | $37K | Hold |
1,550
| – | – | ﹤0.01% | 2385 |
|
|
2021
Q1 | $40K | Buy |
1,550
+520
| +50% | +$13.4K | ﹤0.01% | 2210 |
|
|
2020
Q4 | $20K | Hold |
1,030
| – | – | ﹤0.01% | 2471 |
|
|
2020
Q3 | $13K | Hold |
1,030
| – | – | ﹤0.01% | 2592 |
|
|
2020
Q2 | $12K | Hold |
1,030
| – | – | ﹤0.01% | 2629 |
|
|
2020
Q1 | $8K | Hold |
1,030
| – | – | ﹤0.01% | 2638 |
|
|
2019
Q4 | $18K | Hold |
1,030
| – | – | ﹤0.01% | 2461 |
|
|
2019
Q3 | $12K | Hold |
1,030
| – | – | ﹤0.01% | 2658 |
|
|
2019
Q2 | $23K | Buy |
+1,030
| New | +$23K | ﹤0.01% | 2368 |
|